GSK-HZC102871

Study Sponsor: GSK

Study Title

HZC102871: A 52-week efficacy and safety study to compare the effect of three dosage strengths of Fluticasone Furoate/GW642444 Inhalation Powder with GW642444 on the Annual Rate of Exacerbations in Subjects with Chronic Obstructive Pulmonary Disease (COPD)

Medicine or Vaccine (generic name)

fluticasone furoate/vilanterol

Sponsor Identification Number

HZC102871

Trial Registry Identification Number(#'s)

NCT01009463 2009-013063-19

Medical Condition

Pulmonary Disease, Chronic Obstructive

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=102871

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT01009463

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2009-013063-19

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

September 2013